Revenue Increased 17% Quarter over Quarter Operating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., Nov. 14, 2024 (GLOBE NEWSWIRE) -- . (“Vivos” or the ...

Completed dosing of 115 participants in a bioavailability and bioequivalence (BA/BE) clinical trial in Australia for IHL-42X, an investigational treatment for obstructive sleep apnea in July 2024.

As we age, our sleep needs and habits change. While we tend to sleep more in our younger years, this gradually decreases as ...

"If you have obstructive sleep apnea, yes, this can be very dangerous." "There is limited evidence on the benefits of mouth taping and I would be very careful — and even talk to your health care ...

Data for tirzepatide, the chemical compound Lilly sells as Mounjaro and Zepbound, has separately showed the blockbuster ...

An established association also exists between periodontitis and obstructive sleep apnea, although the data remain ...

LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development ...

Researchers released new clinical guidelines for treating restless legs syndrome (RLS), emphasizing patient-centered care and ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Factors including stress, hormones, anxiety, medication, and physical activity also contribute to what may be considered a ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...